Virbac SA/ADR (VRBCF) — Earnings Call Analysis & IR Page

Virbac SA/ADR is a Healthcare company operating in Drug Manufacturers - General with a $3.21B market cap.

Most recent earnings call: Q2 FY25 on Sep 15, 2025.

3 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for VRBCF.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 3 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for VRBCF.

$ curl https://api.spokenalpha.com/v1/companies/VRBCF

Get an API key API docs

FAQ

Frequently asked about VRBCF

Where can I find Virbac SA/ADR's (VRBCF) earnings call transcripts?

Spoken Alpha indexes VRBCF's earnings call transcripts at https://spokenalpha.com/companies/VRBCF. Each call links to attributed speakers and parsed analyst Q&A.

When was Virbac SA/ADR's most recent earnings call?

Virbac SA/ADR (VRBCF) held its most recent earnings call on 2025-09-15, covering fiscal Q2 2025.

What sector is VRBCF in?

Virbac SA/ADR (VRBCF) operates in the Healthcare sector (Drug Manufacturers - General industry).

Overview